Remove Food and Drug Administration Remove Pharmaceutical products Remove Specialization
article thumbnail

LAMP assays to enable rapid and sensitive detection of BCC

European Pharmaceutical Review

According to researchers, a ribB -based colorimetric loop-mediated isothermal amplification (LAMP) assay could become a fast and easy-to-perform detection method for testing non-sterile pharmaceuticals for BCC. Burkholderia species are one of the primary causes of non-sterile pharmaceutical product recalls and accounted for 45.3

article thumbnail

Cleanroom microbiology: single-temperature incubation for EM

European Pharmaceutical Review

Information can be found in certain US pharmacopeia guide chapters, such as USP <1116>, 1 as well as guidance from the US Food and Drug Administration (FDA) and World Health Organization (WHO) but none of these are regulatory requirements. From this observation, all options are possible.

article thumbnail

Uri Goren

Cadensee

48:12 What is Uri Gorenseeing that is special in the Israeli Digital Health ecosystem? It might be silly question but bringing a drug to market takes many, many years. So, do you listen to them at the point when a pharma company decides what drug it needs to make? When do you think it is the most important?